Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Androgen receptor mutations from androgen independent prostate cancer are associated with previous hydroxyflutamide treatment

Androgen receptor mutations from androgen independent prostate cancer are associated with previous hydroxyflutamide treatment. Keystone Symposium. 1998; 318.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.